<DOC>
	<DOCNO>NCT00325455</DOCNO>
	<brief_summary>To assess cholesterol change effect MK0859 patient primary hypercholesterolemia mixed dyslipidemia .</brief_summary>
	<brief_title>MK0859 Dose-Ranging Study ( 0859-003 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type V</mesh_term>
	<mesh_term>Anacetrapib</mesh_term>
	<criteria>Eligible patient men woman nonchild bear potential , 18 75 year age diagnose high cholesterol Patients CHD CHDequivalent disease ( except diabetes ) Diabetics statin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>